Senior insider sale
CHIEF FINANCIAL OFFICER at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$48.7K
36.34K shares
What this filing means
PARKER GEOFFREY M. plans to sell 36.34K shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $48.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/21/2026ACC: 0001491874-26-000003
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
36.34K
Shares to sell
$48.7K
Approx. market value
100K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
10/20/2026
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/20/2026 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
36.34K
Market value
$48.7K
10/21/2026
Total
Units
36.34K
Value
$48.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/21/2026 | 36.34K | $48.7K | NASDAQ | Planned |
| Total | 36.34K | $48.7K | ||